The consortium project "European Patients‘ Academy on Therapeutic Innovation" (EUPATI), funded by the Innovative Medicines Initiative, will provide scientifically reliable, objective, comprehensive information to patients on medicines research and development. It will increase the capacities and capabilities of well-informed patients and patient organisations to be effective advocates and advisors in medicines research, e.g. in clinical trials, with regulatory authorities and in ethics committees. More about the Patients' Academy
For anyone who has followed the progress of EUPATI, the European Patients’ Academy on Therapeutic Innovation, from its early beginnings the project’s first full conference with a 183 participants, held in Rome on 19 April 2013, was a revelation.
Please join the EUPATI Network! The Network is open to patients and patient organisations, caregivers, academia, pharmaceutical & biotech companies, journalists, and anyone else interested in finding information on medicine research & development in lay language. Membership in the network is free of charge. Being a member of the EUPATI Network provides the following benefits:
Results of first steps in the "information needs and gap analysis" available to EUPATI Network members
To help understand what patient-centric educational material on medicines R&D is already existing in Europe and in what quality, EUPATI started to collect, catalogue and review existing information, education and training (IET) resources aimed at patients on the topic of medicines development through an intensive internet research and with input from patient organisations and other stakeholders. The list of third-party resources is now available here for EUPATI Network members (after registration and login).